By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
GH insiders were on both sides of the trade this year. Buys came to roughly $78,000 (one buyer), sales to $173.9 million (15 sellers).
The largest purchase came from Kalia Kumud (Executive Officer), about $78,000.
Zooming out by quarter: 7 quarters in a row of net selling by insiders. Insiders bought in 1 of the last 7 full quarters. GH also shows up in congressional disclosures: 1 reported trade from one lawmaker in two years. Big money check: 597 institutions held GH as of Q2 2026, and more funds bought than sold.
Are insiders buying or selling GH stock?
In the last 12 months Guardant Health, Inc. insiders made open-market purchases worth about $78,000 and sales worth about $173.9 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in GH?
The most recent open-market insider trade in GH was filed on 2026-09-17.
How many institutions own GH?
597 investment managers reported holding GH in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded GH?
Yes. Members of Congress reported 1 trades in GH over the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).